RTI's goal for this investigation was to identify fetal genetic variation associated with the higher risk of preterm birth (PTB)-related outcomes and to identify cytokines that explain this association. By identifying high-risk neonates, the analyses will enhance understanding of the pathophysiology and biological mechanisms leading to PTB-associated outcomes and suggest intervention strategies.